Rappaport Reiches Capital Management LLC Grows Stock Position in CME Group Inc. (NASDAQ:CME)

Rappaport Reiches Capital Management LLC increased its holdings in CME Group Inc. (NASDAQ:CME) by 2.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,175 shares of the financial services provider’s stock after buying an additional 579 shares during the period. CME Group comprises about 1.8% of Rappaport Reiches Capital Management LLC’s holdings, making the stock its 12th largest position. Rappaport Reiches Capital Management LLC’s holdings in CME Group were worth $7,209,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. raised its stake in CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock valued at $7,952,273,000 after purchasing an additional 326,623 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider’s stock valued at $1,946,717,000 after acquiring an additional 104,697 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares during the last quarter. Norges Bank acquired a new position in shares of CME Group during the 4th quarter valued at about $1,107,389,000. Finally, FIL Ltd increased its stake in shares of CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider’s stock valued at $947,821,000 after acquiring an additional 61,908 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Price Performance

Shares of CME Group stock opened at $273.99 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s 50-day simple moving average is $274.17 and its 200-day simple moving average is $255.51. CME Group Inc. has a twelve month low of $192.11 and a twelve month high of $290.79. The firm has a market cap of $98.73 billion, a P/E ratio of 27.56, a price-to-earnings-growth ratio of 3.72 and a beta of 0.45.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $2.50 earnings per share. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group’s dividend payout ratio (DPR) is presently 50.30%.

Analyst Ratings Changes

A number of research analysts have recently commented on CME shares. Barclays upped their price objective on shares of CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 23rd. Piper Sandler increased their price objective on shares of CME Group from $275.00 to $283.00 and gave the company an “overweight” rating in a research report on Tuesday, April 8th. Oppenheimer increased their target price on CME Group from $282.00 to $300.00 and gave the company an “outperform” rating in a research note on Wednesday, June 4th. Bank of America increased their target price on CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Finally, Raymond James Financial upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price for the company in a research note on Monday, March 10th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $258.20.

Insider Buying and Selling at CME Group

In related news, insider Derek Sammann sold 4,650 shares of the business’s stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the completion of the sale, the insider now directly owns 8,336 shares of the company’s stock, valued at $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Charles P. Carey sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director now directly owns 4,900 shares of the company’s stock, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock worth $3,680,610 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.